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How fluorescent labelling alters the solution
behaviour of proteins
M. K. Quinn,a N. Gnan,b S. James,a A. Ninarello,c F. Sciortino,bc E. Zaccarellibc and
J. J. McManus*a
A complete understanding of the role of molecular anisotropy in directing the self assembly of colloids
and proteins remains a challenge for soft matter science and biophysics. For proteins in particular, the
complexity of the surface at a molecular level poses a challenge for any theoretical and numerical
description. A soft matter approach, based on patchy models, has been useful in describing protein
phase behaviour. In this work we examine how chemical modification of the protein surface, by addition
of a fluorophore, affects the physical properties of protein solutions. By using a carefully controlled
experimental protein model (human gamma-D crystallin) and numerical simulations, we demonstrate
that protein solution behaviour defined by anisotropic surface effects can be captured by a custom
patchy particle model. In particular, the chemical modification is found to be equivalent to the addition
of a large hydrophobic surface patch with a large attractive potential energy well, which produces a
significant increase in the temperature at which liquid–liquid phase separation occurs, even for very low
fractions of fluorescently labelled proteins. These results are therefore directly relevant to all applications
based on the use of fluorescent labelling by chemical modification, which have become increasingly
important in the understanding of biological processes and biophysical interactions.
Introduction
The ability to harness the versatility of anisotropic colloids to build
new materials is of significant interest to soft matter scientists.1,2
Advances in synthesis have allowed these materials to be exploited
as biomaterials and/or photonic devices.1,3 Concurrently, develop-
ment of patchy particle models has occurred in which isotropic
interaction potentials are replaced by those incorporating aniso-
tropy, by specifically defining regions on the particle surface with a
number of fixed (attractive) potentials.4–6 Here, there is a direct
analogy to be drawn with proteins. Proteins can also be considered
as patchy particles, in which the diversity in the chemical surface,
due to variations in the surface exposed amino acids, creates
anisotropy at a molecular level.7 Indeed, it is widely acknowledged
that protein phase behaviour can only be fully explained by
accounting for these anisotropic effects.8,9
The modification of proteins by chemical methods is a
versatile mechanism to label a protein for detection, or to modify
its behaviour, for example by (PEG)ylation, which increases the
number of potential variations (and therefore functions) of a
particular protein.10–13 It is currently exploited for several
applications, ranging from the adaptation of therapeutic bio-
molecules to improve stability and/or function to the produc-
tion of novel, functional materials and bottom-up approaches
to synthetic biology.10,14,15 One of the most useful ways that
chemical modification is already exploited is for the fluorescent
labelling of proteins, which allows direct visualisation of bio-
molecules in situ, with increasing resolution due to the ongoing
development of specialised imaging techniques.16,17 Indeed,
exciting advances in both microscopy and single-molecule
detection are currently used for investigating protein distribu-
tion, translocation and interactions both in vitro and in vivo.18
Covalently attached fluorescent dyes have also been used as a
means to screen for the formation of protein crystals.19 Thus,
the use of fluorescent labelling of proteins plays an important
role for the exploration and understanding of the mechanisms
involved in many biological problems, such as intra/inter-cellular
communication, genomics, unravelling the origins of pathologies
associated with protein condensation diseases and the mecha-
nisms that govern protein-self association during the production
of proteins as therapies.12,18,20,21 To fluorescently label proteins,
there are currently three main established strategies; small
organic molecules that are covalently attached to the biomolecule
of interest, fusion proteins in which an inherently fluorescent
protein is co-expressed (or fused) with the protein of interest or
the use of quantum dots (or small molecule fluorescent dyes),
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that are functionalised to form a biotin–avidin pair with the
biomolecule under study.22–24 Of these three routes, covalent
attachment of an organic fluorophore is considered to be the
most versatile method of labelling for fluorescence imaging
and sensing of biological specimens.22
While the pace of advances in fluorescence imaging and
single molecule analysis increases rapidly, little consideration has
been given to the impact that fluorescent labelling of proteins has
on protein solution behaviour and if these need to be considered
when interpreting fluorescence data. The solution behaviour of a
protein is very sensitive to changes in its environment.25 Protein
solution behaviour is also sometimes dramatically altered by
(comparatively minor) changes to the protein surface, for example
by mutagenesis, specific binding of ions or by changes in pH and
this can have consequences for the pathogenesis of several known
protein condensation diseases.26–28 Hence, one would also expect
a significant impact due to the presence of a fluorescent label.
Some studies have discussed the role that fluorescent labelling
has on specific protein characteristics; bovine serum albumin
(BSA) labelled with fluoroscein isothiocyanate (FITC) exhibited
a larger diffusion coefficient and higher levels of irreversibly
adsorbed proteins at the oil–water interface.29 A chemically
modified green fluorescent protein (GFP) exhibited a more acidic
pI than the unlabelled protein.30 Several different small molecule
fluorophores have also been investigated to determine which had
least effect on cellular function and adherence of leucocytes to
endothelial cells.31 A further study has shown that monomerically
labelled and mixtures of unlabelled and labelled Gag (a viral
protein) assemble into morphologically indistinguishable clusters
at a lipid membrane.32
It is therefore reasonable to ask how and to what extent
fluorescent labelling of proteins alters the solution behaviour
and if this has consequences for understanding protein inter-
actions within the cellular environment and more widely in
interpreting analytical data which requires proteins to be
labelled. To do this directly and unambiguously, we examine
variations in the phase behaviour of protein solutions upon
addition of labelled proteins. Phase diagrams are used to char-
acterize the interactions between macromolecules, including
colloidal particles and proteins.8,25,33,34 These studies have shown
that the effective inter-protein interaction potential results from
the complex interplay of both attractive and repulsive contribu-
tions.35 Proteins are inherently anisotropic, since each surface
exposed amino acid contributes to varying degrees to the overall
net-interaction potential.9 This anisotropy has been shown to
have a direct influence on protein phase behaviour.26,33,36,37
Liquid–liquid phase separation (LLPS) occurs for proteins inter-
acting via short-ranged net attractive forces.25,33,34 Indeed, the
temperature at which LLPS occurs is sensitive to the strength of
net attraction between proteins in solution and can be used to
probe the relative changes in protein inter-particle interactions as
a result of altered protein chemistry, changing solution condi-
tions or the presence of a second protein type.38,39
In this study, we experimentally assess the phase diagram
for human gD-crystallin (HGD), which is a structural protein in
the eye lens that undergoes LLPS due to short-ranged attractive
interactions which dominate its behaviour at physiological pH
(at the pI of the protein).9,37,39,40 The native protein is remark-
ably stable in vivo.41 Several point mutations in HGD have been
linked to congenital cataract formation due to significantly
decreased solubility of the protein at body temperature leading
to increased light scattering and, eventually, blindness.37,40–44
Therefore, LLPS of HGD is a readily quantifiable phase transi-
tion through which the effect that the addition of a fluorescent
dye, by covalent attachment of an organic fluorophore, can be
probed. Additionally, the surface chemistry of HGD ensures that
the both the position and number of small molecules conjugated
to the protein can be controlled.
We will quantify the changes in phase behaviour of HGD
upon addition of a small amount (less than 1% total protein) of
fluorescently labelled proteins. We will demonstrate that, even
when the fraction of labelled proteins is very low, the chemical
modification introduced by small molecule tagging leads to a
collective increase in net attraction between proteins in solu-
tion. To account for these surprising results, we propose the
hypothesis that the addition of a fluorescent molecule to a protein
is the equivalent of adding a large attractive hydrophobic patch to
the surface of a protein. By comparison of experimental results
with numerical investigations of a specifically devised patchy
particle model, we will provide a description that accounts for
the increased tendency of protein solutions containing labelled
proteins to phase separate. We will also show how fluorescent
labelling is a simple yet effective way of demonstrating the
directionality of protein–protein interactions by chemical modifi-
cation (at two different amino acid positions) of HGD. Our results
are therefore relevant for all current uses of fluorescent labelling
of proteins, clearly indicating that the enhanced protein–protein
interactions need to be taken into account for a correct compar-
ison between labelled and unlabelled conditions.
Methods
Experiments
Sample preparation and experimental techniques
Preparation of materials. Analytical grade sodium hydroxide,
glacial acetic acid, sodium azide, sodium dihydrogen ortho-
phosphate dihydrate, dibasic sodium phosphate heptahydrate,
sodium chloride, sodium borate, dithiothreitol (DTT), hydro-
chloric acid, LB Broth, LB agar, magnesium sulfate hepta-
hydrate, and ethylenediaminetetraacetic acid (EDTA) were
purchased from Fisher Scientific (Dublin, Ireland). Tris hydro-
chloride was purchased from Merck Millipore (Cork, Ireland).
Dimethylformamide (DMF) was purchased from Romil
(Cambridge, UK) and used without further purification. All
buffers were prepared using Milli Q water. All buffers were
filtered through a 0.45 mm MillexHV syringe filter or a 0.45 mm
nylon membrane filter (Millipore, Cork, Ireland) prior to use.
Amicon Ultra 4 ml centrifugal filters were used for buffer
exchange (Millipore, Cork, Ireland). Protein concentration was
determined using a mass extinction coefficient value equal to
2.09 mg1 ml cm1.
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Expression, purification and characterisation of protein. HGD
was prepared by recombinant methods as previously described.45
HGD purity was confirmed at 498% by SDS-PAGE and size
exclusion HPLC. The molecular weight of HGD was confirmed
to be 20 608  1 Da by intact molecular weight analysis using
electrospray ionisation mass spectrometry, carried out in
‘FingerPrints’ Proteomics Facility at the University of Dundee,
Scotland, UK and is in agreement with previously published
data.45 The volume fraction is calculated using the expression
c = fn where c is the concentration in mg ml1, f is the volume
fraction and n is the partial specific volume equal to 7.1  0.1 
104 ml mg1 for the g crystallins.46
Modification of Lys-2 and Cys-110 amino acid residues. Amine
modification of Lys-2 in HGD was carried out using an AnaTag
HiLyte 405 kit, purchased from AnaSpec (Freemont, CA, USA),
as per supplied instructions via amine modification after puri-
fication. Absorbance values to calculate labelling efficiency were
determined using a Perkin Elmer Lambda 35 UV/Vis spectro-
photometer and UV Win Lab – Scan Lambda 35 software. Thiol
modification of Cys-110 in HGD using DyLight 405, Malemide
(Pierce Biotechnology, Rockford, IL, USA) was performed as per
manufacturer’s instructions after protein purification. Labelling
efficiency was determined spectroscopically as for amine modi-
fication. Fluorescently labelled proteins were exchanged with
0.1 M sodium phosphate buffer at pH 7 prior to use.
Modification with FITC. HGD was labelled using FITC (Pierce
Biotechnology, Rockford, IL, USA) as per supplied instructions
after purification. Conjugation efficiency was determined spectro-
scopically as permanufacturer’s instructions after extensive washing
using a Perkin Elmer Lambda 35 UV/Vis spectrophotometer and UV
Win Lab – Scan Lambda 35 software.
Circular dichroism spectra. Circular dichroism (CD) spectra
were attained for samples of unlabelled HGD, amine modified
HGD and thiol modified HGD at a concentration of 0.1 mgml1 in
0.1 M sodium phosphate buffer at pH 7 using near and far UV
wavelengths at the Institute of Molecular, Cell, and Systems
Biology, College of Medical, Veterinary, and Life Sciences, Univer-
sity of Glasgow, Scotland, UK using a JASCO J-810 spectro-
polarimeter. OriginPro 9.1 was used to construct the spectra.
Phase separation measurements. Liquid–liquid coexistence curves
were measured for unlabelled HGD, mixtures of unlabelled HGD
and amine modified HGD, and mixtures of unlabelled HGD and
thiol modified HGD using amethod outlined previously.25 A Perkin
Elmer Lambda 35 UV/Vis spectrophotometer and UV Win Lab –
Timedrive Lambda 35 associated software was used to measure the
percentage transmission of light (l = 600 nm). A Thermo Scientific
K10 water bath attached to a Thermo Scientific D10 temperature
control was used for temperature regulation. The temperature of
the systemwasmonitored using anOmegaHH509R thermocouple.
OriginPro 9.1 was used to construct phase diagrams.
Fluorescence measurements. A Molecular Devices Spectra Max
M2e plate reader and SoftMax Pro 6.2.1. software were used to
spectroscopically measure fluorescence intensity.
Model and simulation details
Model for the unlabelled proteins. The unlabelled HGD
proteins (U-type particles) are modelled based on the work of
H. Liu et al. where Kern–Frenkel patchy particles are comple-
mented with a square-well (SW) attraction.47,48 This model
reproduces the correct width of the experimental coexistence
curve of bovine gamma-crystallin. Thus we represent the unlabelled
proteins as hard spheres of diameter sm interacting via a SW
attraction of width dSW and depth eSW
VSW ~rij
   ¼
1 if ~rij
 osm;
eSW if sm  ~rij
 
0 otherwise:
8>><
>>:
 sm þ dSWsm; (1)
where |rˆij| is the vector between the centres of particles i and j.
In addition the surface of the particles is decorated by four
randomly-located attractive sites (patches) which do not over-
lap. The interaction potential between patches is the product of
a radial contribution modulated by an angular function
VUij = VSW,U (|rˆij|)G(rˆij, rˆia, rˆjb) (2)
where rˆia and rˆjb are the unit vectors from the centre of particle
i( j) to the centre of the a(b) patch on the surface and VSW,U is a
square well potential of width dU,U and depth eU,U. The function
G modulates the potential and depends on the reciprocal
orientation of two particles
G r^ij ; r^ia; r^jb
  ¼ 1 if
r^ij  r^ia4 cos ymaxð ÞU;
r^ij  r^jb4 cos ymaxð ÞU;
(
0 otherwise:
8><
>: (3)
sm and eSW are chosen as the units of length and energy
respectively. The temperature T is measured in units of eSW.
Parameters for the unlabelled patches (U) are shown in Table 1.
This is a modified version of the model used in ref. 47 where
the patches were not randomly located, but arranged in a
tetrahedral geometry on the surface of the particle. This model
captures the experimental value of the critical packing frac-
tion fc = 0.21 for HGD. In addition the model correctly
reproduces the experimental width of the liquid–liquid coexist-
ence curve.
Model for the labelled proteins. Since no minimal models
have been proposed to describe the addition of a fluorescent dye
to a protein, we have accounted for the presence of a fluorescent
dye by adding a fifth patch to the model of the unlabelled
protein. Hence a labelled HGD (L-type particles) is the same as
an unlabelled particle except for the presence of an additional
patch on the particle surface. U-type and L-type particles are
sketched in Fig. 1. Accounting for the differences in chemistry
Table 1 Parameters of the interaction potential for themodel of unlabelled
proteins as in ref. 47
dU,U eU,U cos(ymax)U dSW eSW
0.05 5 0.95 0.5 1.0
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between an aromatic amino acid (i.e. Phenyalanine, Tryptophan,
Tyrosine) and a typical fluorescent dye, we create the additional
patch (L-patch) such that it is wider and more attractive than the
patches on the unlabelled protein. This assumption is reason-
able on the basis that the majority of standard fluorescent
molecules have molecular weights that are significantly larger
than any of the aromatic amino acid side chains on the protein
surface and are also significantly more hydrophobic due to the
presence of several aromatic groups (Fig. 2). Using these con-
siderations, we estimate the size of the patch to be 3–4 larger
than a hydrophobic amino acid.
The label is chemically attached to the surface of the protein
rather than being a composite part of the structure and there-
fore has the potential to extend beyond the surface of the
molecule, thereby allowing contact with more than one other
protein. Hence we allow the L-patch to form more than one
bond with the U-patches of both U-type and L-type particles
(Fig. 1). A second characteristic of the model is that the L-patch
on a particle does not directly interact with a L-patch on another
L-type particle. If this happens it would cause the L-type particles
to associate in small stable clusters since the L–L bond would be
the most energetically favourable. This possibility was excluded
experimentally.
Evaluation of the critical points. To accurately evaluate
the critical point and the liquid–liquid coexistence line of the
unlabelled particles we perform umbrella sampling grand-
canonical Monte Carlo simulations (US-GCMC) and histogram
reweighting.49,50 Thus we identify the correct order parameter
M that, at the critical point, has a probability distribution P(M)
that follows the one typical of the Ising universality class.51–54
This parameter M = r + su is the linear combination of the
number density r and the energy density u trough the field-
mixing parameter s.51,52,55
To locate the critical point we tune the temperature T and
the chemical potential m of the system until the numerical joint
distribution P(N, E; T, m) projected over N shows the double-
peaked shape typical of the Ising probability distribution
P(M); this is the signature of the presence of large density
fluctuations in the system in the vicinity of the critical point.
We then implement a fitting procedure based on the histogram
reweighting technique that allows us to transform the joint
distribution P(N, E; T, m), evaluated at T and m, into P(N, E;
T0, m0) at T0 and m0 and to extract the best values of T0, m0 and s
for which the numerical P(M) is the closest to the Ising distri-
bution.50,51 The reweighting technique is also used to evaluate
the liquid–liquid coexistence line; at temperatures lower than
Tc the liquid–liquid coexistence densities are obtained by
imposing the equality of the areas below the two peaks of the
reweighted P(N, E; T, m) projected over N and centred in Nc =
rcL
3 where rc is the critical density and L is the length of the
simulation box.
The procedure to evaluate the critical point in the binary
mixtures is similar to that employed for the pure system except
for the fact that a different order parameter needs to be con-
sidered. In particular we choose M = rU + arL, where rU(L) is the
number density of the species U(L) and a is a mixing para-
meter.55 Hence the numerical joint distribution P(NU, NL, mU, mL)
will depend only on the number of particles of the two species
and the associated chemical potentials. Note that since the joint
distribution does not depend on the energy, T is a parameter
that cannot be varied to locate the critical points. This means
that for each mU and mL we search for the critical temperature Tc
of a mixture of a given concentration xL(U) of species U and L,
mapping in this way Tc. We then select the specific Tc corres-
ponding to the desired concentration of L-type particles, e.g.
xL = 0.01 to 0.02, to compare with the experimental values of
concentrations of labelled proteins with amine modification.
Results and discussion
HGD has two surface-exposed primary amines (the terminal
amine and e-amine of lysine in position 2). Control of pH during
conjugation ensures that only the free amine of the lysine is
modified by labelling. HGD has 6 unpaired cysteine residues but
only one is surface-exposed (at position 110).45 Therefore, using
commercially available labellingmethodologies, it is only possible
to label HGD in one position on the protein in each case (i.e. for a
particular label type only a single molecule of dye is conjugated
to the protein) (Fig. 3). This allows us to explore both the
chemical and directional anisotropy imposed by the addition of
the fluorophore.
Two commonly used fluorescent dyes were selected initially;
HiLyte Fluor 405 which labels the lysine in position 2 by for-
mation of a carboxamide bond between the reduced e-lysine
group of the lysine and the succinimidyl ester of the dye and
DyLight Maleimide 405, used to label the cysteine residue at
Fig. 1 Patchy particles used for modelling HGD proteins. Particles with
four patches (U-patches) are unlabelled proteins (U-type), while the particle
with green (wider) patch (L-patch) corresponds to a fluorescently labelled
protein (L-type).
Fig. 2 Structure of Phenylalanine (A) and FITC (B).
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position 110 via the formation of a thioether bond between the
reduced thiol group of the cysteine and the maleimide group
of the dye.
For many applications, labelled protein is used at low label-
ling densities in solution in combination with unlabelled protein.
The high sensitivity of fluorescence methods in general requires
low quantities of labelled protein. Using lower amounts of
labelled protein may also be used as a strategy to mitigate any
potential impact labelling may have on the structure or behaviour
of a protein. Typically labelled proteins ranging from xL = 0.0001
to xL = 0.01 (where xL is the fraction of labelled proteins for a
combined protein volume fraction xT = 1) are used. Therefore,
protein labelled by the methods described above, were mixed in
known quantities with unlabelled HGD and the temperature at
which liquid–liquid phase separation occurred was measured at
each composition (Fig. 4a and b).
The temperature at which the onset of liquid–liquid phase
separation occurs is referred to as the phase separation tem-
perature (Tph) and is determined by taking the average of the
Tcloud (defined as the temperature at which the solution clouds
upon cooling (at 50% transmission)), and Tclear (defined as
the temperature at which the solution clears upon reheating)
from the experimental measurements. We observe significant
increases in the liquid–liquid phase separation temperatures
(Tph) for the mixtures in both cases at compositions with
very low fractions of labelled protein (i.e. there is an increase
in the temperature at which the liquid–liquid coexistence
curve is measured). To a first approximation, we can use the
single-component description of the liquid–liquid coexistence
curve to describe the experimental data even for the mixtures
(eqn (4))
f fc
fc
 
¼ A 1 T
Tc
 b
(4)
where f and fc are the volume fraction of the sample and
critical volume fractions respectively; A is a parameter that
determines the width of the liquid–liquid coexistence curve;
T and Tc are the sample temperature and critical temperature
respectively (in Kelvin) and b is an exponent term for the three
dimensional Ising model equal to 0.325.46 The degree to which
Tph changes is, however, different for the two positions at which
the protein was labelled. For the protein mixture containing
protein modified with HiLyte 405 at the amine 2 position, it was
possible to add up to xL = 0.01 of labelled protein before
significant precipitation of protein occurred.
At protein compositions containing up to xL = 0.01 the
protein remained in solution up to a total protein volume
fraction of B0.07. The aggregation that did occur at xL = 0.01
was due to the formation of reversible non-covalent aggregates
above this total protein volume fraction. It was possible to
re-disperse these aggregates upon dilution. For the protein
Fig. 3 Topological rendering of HGD indicating each site used for fluores-
cent labelling. Lys-2 is shown in green and Cys-110 in red.
Fig. 4 Liquid–liquid coexistence curves for unlabelled HGD and binary
protein mixtures in aqueous solution of unlabelled and amine modified
(a and c) and thiol modified (b) HGD with increasing labelled protein
fractions (xL). Panel A indicates binary protein mixtures in aqueous solution
of unlabelled HGD and HGD amine modified with HiLyte Fluor 405. Panel
B shows unlabelled HGD and binary protein mixtures in aqueous solution
of unlabelled HGD and HGD thiol modified using DyLight 405 Maleimide.
Panel C indicates the liquid–liquid coexistence curves for unlabelled HGD
and a binary protein mixture in aqueous solution of unlabelled HGD
and HGD modified using FITC (assuming on average 1 dye molecule per
labelled protein).
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modified at the cysteine 110 position, it was only possible to
add labelled protein fractions, xLE 0.0002 before precipitation
occurred. We also observe a change in the shape of the liquid–
liquid coexistence curve with increasing fractions of labelled
protein in each case. It was not possible to obtain further points
on the liquid–liquid coexistence curve experimentally, since
further concentration of protein within the ranges that we have
measured resulted in precipitation (due to the net increase in
attraction).
To ensure that these observations were not related only to the
specific chemistry of the dyes that we selected, we also labelled
protein with FITC, which is a widely used fluorescent dye (for
which the chemical structure is known). In this case, we have not
specifically labelled a particular amino acid (since FITC will
covalently attach to both primary and secondary amines). Again,
the FITC labelled proteins were used in mixtures with unlabelled
HGD. A significant change in the liquid–liquid coexistence curve
is also observed in this case (Fig. 4c). Therefore, the addition of
the labelled proteins (and therefore a strong hydrophobic patch)
alters the solution behaviour, the extent of which is governed by
both the specific chemistry of the dye (i.e. its hydrophobicity,
and therefore the strength of the attraction) and also by the
position on the protein surface in which the label is placed.
The critical point for several gamma crystallins has been
measured previously and occurs at fc = 0.21 (300 mg ml
1) and
277 K (4 1C).56–58 To estimate the critical temperature for each
of the protein mixtures, we fit each liquid–liquid coexistence
curve using eqn (4), assuming that the critical volume fraction
(fc) did not change with the addition of labelled protein. Values
for Tc (the critical temperature) and A (related to the width of
the liquid–liquid coexistence curve) are shown in Table 2. The
width of the liquid–liquid coexistence curve is determined by the
range of the inter-protein interaction, with a decrease in width
indicative of an increase in the range of the interaction.57,59 The
decreasing width of the liquid–liquid coexistence curve observed
indicates that the range and strength of the attractive interaction
is increasing. This is consistent with our view that fluorescent
labelling is the equivalent of adding a hydrophobic patch that
increases inter-protein attraction.
Furthermore, both the molecular weight and number of
hydrophobic groups in the fluorescent dye are significantly
greater than for a hydrophobic amino acid (Fig. 2). Therefore,
we expect that the strength of the attraction at this patch to be
higher than other attractive patches on the protein surface.
These results clearly show that upon increasing labelled protein
fractions a significant increase in net-attraction of the system is
observed.
The above results are based on the strong assumption that,
within the volume fraction range that we have probed, the protein
remains monomeric, the critical volume fraction does not change
and there is no significant change to protein structure. We per-
formed SE-HPLC (size exclusion high pressure liquid chromato-
graphy) on the protein mixtures to determine if it was possible to
detect even small amounts of protein aggregates in our samples.
None were detected, even at high total protein volume fraction
(f = 0.07). The presence of protein aggregates has been pre-
viously shown to increase Tph, but we find no evidence that this
is the source of the increase in Tph in our case.
60,61
To probe this further, we induced LLPS in a sample and
allowed the concentrated and dilute phases to fully phase sepa-
rate.62 We then measured both the total protein volume fraction
and the fluorescence intensity in each of the two phases (Fig. 5).
The protein volume fractions measured in each phase are con-
sistent with a critical volume fraction that does not change upon
the addition of labelled protein (to within the experimentally
measureable range). Furthermore, the measurements clearly indi-
cate that the density of labelled protein in the concentrated phase
is higher than in the dilute phase and therefore that the fluores-
cently labelled protein preferentially partitions into the concen-
trated phase after phase separation. In this case before LLPS,
labelled protein is present at xL = 0.002. After phase separation the
labelled protein fraction in the dilute phase is xL = 0.0012 and in
the concentrated phase is xL = 0.0025.
We also performed circular dichroism spectroscopy to deter-
mine if structural change to the protein occurs after labelling
(Fig. 6). A structural change as a result of unfolding can lead to
an increase in net attraction due to exposure of hydrophobic
amino acid resides from the protein interior. To establish if
this was the case for our protein mixtures in aqueous solution,
Table 2 Estimated changes in critical temperature (DTc) for each protein
mixture with different labelled protein fractions (xL) at a total protein
volume fraction of 0.21
Labelled protein Tc (K) DTc (K) A
Unlabelled HGD 277 0 2.6
HiLyte Fluor 405 labelled amine, xL = 0.002 280 3 2.5
HiLyte Fluor 405 labelled amine, xL = 0.006 287 10 2.2
HiLyte Fluor 405 labelled amine, xL = 0.0075 297 20 1.8
HiLyte Fluor 405 labelled amine, xL = 0.01 308 31 1.6
DyLight 405 Maleimide labelled thiol, xL = 0.0001 291 14 2.1
DyLight 405 Maleimide labelled thiol, xL = 0.0002 301 24 1.9
FITC labelled HGD, xL = 0.0002 297 20 1.9
Fig. 5 Liquid–liquid coexistence curves for unlabelled HGD and for a
protein mixture containing xL = 0.002 amine modified HGD (with HiLyte
Fluor 405). The diamonds indicate the volume fractions for the dilute
phase (f = 0.067) and concentrated phase (f = 0.351) after liquid–liquid
phase separation. The dashed line is a tie-line and connects the pair of
volume fractions after phase separation. The measurements are consistent
in both cases with a critical volume fraction fc = 0.21.
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we used far and near circular dichroism (CD) spectroscopy for
comparative analysis of secondary and tertiary structure between
the unlabelled protein and the protein labelled at both positions.
No significant change in protein structure is observed.
We have so far demonstrated that fluorescent labelling of
HGD in position 2 via an amine modification and at position
110 via a thiol modification leads to an increase in the net
attraction between proteins in solution. This increase is unrelated
to the formation of protein aggregates, although the increase in
net attraction does eventually lead to aggregation. When aggre-
gation does occur, it involves a significant volume of the
protein material (not only the labelled protein) and appears
to arise due to the collective increase in net attraction (rather
than by nucleation via the labelled protein). The increase in
attraction arises from a small amount of labelled protein in
solution and not as a result of a significant change to the
protein structure. While the effect is not limited to a single type
of small molecule label, the extent of the impact is related both
to the specific chemistry of the dye and the position on the
protein in which the modification is made. While it is not overly
surprising that the addition of a fluorescent (hydrophobic)
molecule has some impact on solution behaviour, the very low
labelled protein fractions at which a significant effect occurs is
somewhat unexpected.
To gain a microscopic understanding of the primary mecha-
nism responsible for the shift in Tc for LLPS when a small frac-
tion of protein is labelled, we numerically study a simple patchy
model which incorporates the essential elements required to
describe the experimentally observed behaviour. Patchy particle
models with implicit solvent have been used to describe the
phase behaviour of rubredoxin and lysozyme.47,61,64 To show
that the model used in this work (eqn (1) and (2) and para-
meters reported in Table 1) correctly captures the value of the
critical volume fraction as well as the experimental width of the
liquid–liquid coexistence curve of HGD we report a comparison
between numerical and experimental data in Fig. 7.
To model unlabelled–labelled interactions we have per-
formed a study in which we vary the parameters characterising
the L-patch: attraction strength eL,U, angular width (ymax)L and
width of the patch dL,U, aiming to achieve an increase of Tc in
agreement with experimental results. In Table 3 we summarise
all the different combinations of parameters for the L-patch
and the corresponding values of fc and Tc with respect to
the critical temperature of the unlabelled system (Tc/T
U
c ). The
resulting fits to the Ising probability distribution for estimating
the critical point are shown in Fig. 8 for unlabelled particles
and mixtures with xL B 0.02.
Most of the simulations have been carried out with a wide
angular width compared to that of the U-patches, in order
to allow for multiple bonding. The bonding volume, i.e. the
volume available to form bonds with other particles depends
Fig. 6 Near (a) and far (b) UV spectra showing unlabelled HGD (black),
amine modified HGD (green) and thiol modified HGD (red). While there is
no change in the secondary structure of the protein for either modifica-
tion, there is a slight perturbation in the near UV spectral data in the region
corresponding to phenylalanine (255 nm to 270 nm) for the amine
modified protein.63 There is only 1 phenylalanine in close proximity to
lysine in position 2 which is the phenylalanine in position 11. However, the
CD spectrum indicates that this change in structure is very local and does
not significantly impact the protein structure. There is no measured change
in the tertiary structure for the thiol modified protein.
Fig. 7 Comparison between the experimental liquid–liquid coexistence
curve of unlabelled HGD protein and different numerical models. Circles
are results for the Kern–Frenkel patchy model with four patches randomly
distributed on the surface and complemented with a SW attraction. The
thick dashed line is the liquid–liquid coexistence curve of a simple SW
model from ref. 61: the isotropic attraction captures the position of the
critical volume fraction but doesn’t quantitatively describe the amplitude
of the liquid–liquid coexistence curve. Solid lines are fits to the critical
scaling to describe the liquid–liquid coexistence curve. Tc is the critical
temperature. For the chosen model we find Tc = 0.8184.
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on the angular width and on the interaction width. Whenever
the condition
sin ymaxð ÞL4
1
2 1þ dU;L
  (5)
is satisfied, the patch can be involved in more than one bond.
We note that, since the bonding angle is already very wide,
the increase of the interaction width does not contribute to a
significant increase of the critical temperature. On the other end,
a further increase of the bonding angle would create overlaps
with the other patches of the same particle. Finally, if the L-patch
is too attractive, bonds with other proteins becomes irreversible
and it is not possible to use grand-canonical simulations to
estimate the critical point of the system.
In our simulations this occurs for bonding energy eU,L/eU,U 4
1.5 (when the bonding angle of the L-patch is set to (ymax)L =
0.723 and the width of the patch is dU,L = 0.175). Hence we cannot
directly probe the range of bonding energies directly relevant
to experiments, where the energetic contribution brought by
the fluorescent molecule is estimated to be 3–4 times larger
than the typical protein–protein attraction. As a consequence,
to allow for a comparison with experiments we need to resort to
extrapolation of the critical temperature to higher bonding
energies. For instance, focusing on the case in which the com-
position of the labelled proteins is xLB 0.02, the extrapolation
values of the bonding energies comparable to the energetic
contribution brought by the fluorescent molecule in the experi-
mental system is shown in Fig. 9. The addition of a very small
percentage of labelled proteins, as little as xL = 0.02 produces a
significant increase in the critical temperature of the mixtures,
in qualitative agreement with experimental results. We also see
a shift of the critical volume fraction to larger values when
compared to the unlabelled system. However a crude extrapola-
tion suggests that this would shift to fc = 0.23 when eU,L/eU,UB 4.
HGD in mixtures with the amine modified protein at
xL = 0.002, for which we have an experimental point on the
descending arm of the liquid–liquid coexistence line, the
experimental data is consistent with a similar critical volume
Table 3 Parameters of the L-patch and corresponding critical tempera-
tures for different fractions of labelled protein
eU,L/eU,U (ymax)L dU,L xL (%) Tc/T
U
c fc
1.0 0.723 0.175 1.12 1.0056 0.214
0.723 0.175 1.57 1.0081 0.215
0.723 0.175 2.14 1.0099 0.214
0.723 0.175 2.90 1.0130 0.214
1.1 0.723 0.175 1.13 1.0062 0.215
0.723 0.175 1.48 1.0081 0.214
0.723 0.175 2.16 1.0105 0.214
0.723 0.175 3.10 1.0142 0.214
1.2 0.723 0.175 1.97 1.0105 0.217
0.723 0.175 1.95 1.0105 0.217
0.723 0.175 2.61 1.0105 0.213
0.723 0.175 1.62 1.0105 0.217
0.723 0.175 2.05 1.0111 0.217
0.723 0.175 2.60 1.0142 0.216
0.723 0.175 4.16 1.0203 0.217
1.5 0.723 0.175 1.66 1.0105 0.217
0.723 0.175 2.23 1.0126 0.219
0.723 0.175 2.51 1.0139 0.219
Fig. 8 Top Panel: Best fit of numerical data (full circles) to the Ising order
parameter distribution P (M = rU + su) (solid line) of monodisperse system
of unlabelled (U-type) particles. The mixing parameter is s = 0.028. The
simulation box is L = 5. Bottom Panel: the same as before but for the binary
mixtures with xL B 0.02, when the interaction strength of the L-patch
(eU,L/eU,U) is varied. The order parameter is given byM = rU + arL. For all the
three curves a = 0.001. The simulation box is L = 5. The angular width of
the L-patch is set to (ymax)L = 0.723 and the width dU,L = 0.175.
Fig. 9 Evolution of the critical temperature of the mixture of labelled and
unlabelled particles (normalised to the critical temperature of the unlabelled
system TUc ) as a function of the bond energy between a U-patch and a
L-patch eL,U. The fraction of labelled particles is xLB 0.02. The darker area
in the plot corresponds to the range of interaction energies comparable to
experiments. Inset: critical volume fraction fc as a function of eL,U.
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fraction (fc = 0.21) as for the unlabelled case, although an
increase to higher values cannot be excluded since the fitting
function (eqn (4)) strictly holds only for one-component systems.
Finally, we have also monitored the relative concentration of
labelled proteins in the two phases of the liquid–liquid phase
separated mixtures, finding that they are present only in the
dense phase. This is due to the larger strength of the fluorescent
label attraction which forms longer-lived bonds with respect to
unlabelled proteins making it favourable for them to be in the
concentrated phase. This is consistent with the experimental
results where a 1 : 2 ratio of labelled protein is found between the
dilute and concentrated phases (from an initial xL = 0.002 of
labelled protein) (Fig. 5).
Conclusion
We have demonstrated that small molecule fluorescent labelling
of protein increases the net attraction in protein solutions at low
labelled protein fractions. The temperature at which liquid–
liquid phase separation for HGD occurs increases when using
fluorescent dyes with different chemistries and is also affected by
positioning these dyes in different sites on the protein. By careful
control of the labelling conditions, it was possible to ensure that
each labelled protein contained only 1 dye molecule and hence
the ratio of labelled to unlabelled protein could be unambigu-
ously calculated. It appears that both the specific chemistry of the
dye molecule and the position at which it is located on the
surface of the protein are important in determining the extent to
which the net attraction increases. To understand the micro-
scopic basis for these observations, we have numerically assessed
a simple patchy particle model in which unlabelled proteins are
represented by a 4-patch particle complemented with an isotropic
SW potential and labelled proteins by the addition of a fifth patch
to this model. Performing Monte Carlo simulations for mixtures
of these particles at labelled protein compositions within the
range of the experimental values, we find a good agreement
between the model and experiments. The net increase in attrac-
tion in the system is derived from an increase in the total number
of bonds due to the addition of a large, hydrophobic region on
the protein surface, which occurs upon labelling. We note that
while a simple model can quantitatively describe the liquid–
liquid phase coexistence of the unlabelled HGD solutions, it does
not fully describe the chemical modification induced by the
fluorescent labelling in terms of the interaction potential. Our
attempt to model this by the presence of an additional patch only
qualitatively captures the experimental behaviour. We have tested
different potential models (e.g. with and without the presence of
the isotropic SW) as well as different combinations of parameters
of the fifth patch but we have not been able to reach quantita-
tively the same change in the critical temperatures. However, the
fact that the critical volume fraction does not change significantly
is well reproduced by the present model. These findings suggest
that more fundamental work is needed to understand how to
model correctly the fluorescent label in a quantitative way. There
may of course be other surface effects with the addition of dye
that we have not yet considered. For example the fluorescent dye,
when present alongside other hydrophobic amino acids on
the surface, could increase the effective size of the additional
attractive site on the protein surface. These possibilities will be
explored in future work.
The current work however provides important observations.
While anecdotally we know that fluorescent labelling can alter
the solubility of the protein (and this has led to a number of
new dyes being developed to offset these effects), we explain for
the first time that the origin of the decrease in solubility is not
due to the formation of aggregates in itself (although this is a
downstream consequence) or a significant change in protein
structure, but as a result of a net-increase in attraction due to
an increase in the total number of attractive sites in the system.
We have also demonstrated that these effects can be significant,
even at sites on the protein which may be considered biologically
inert. While the cysteine at position 110 for HGD is important in
maintaining its solubility, the amine in position 2 has no known
biological significance and there are no known mutations at
this position for this protein which result in a change in protein
solution behaviour.
With the increasing dependence on fluorescence methods to
understand protein behaviour, this study provides for the
first time a quantitative assessment of the effects that these
established methodologies can have on the stability of protein
solutions. Thus, while it is clear that the use of fluorescence by
chemical modification requires careful control and may best be
limited to the lowest possible amounts of labelled protein,
it also suggests that the interpretation of results involving even
small amounts of fluorescently labelled protein must account for
these important effects. More broadly, these results may suggest
a more general mechanism by which anisotropic protein–protein
interactions in protein mixtures determine solution behaviour.
Acknowledgements
JJMcM, MKQ and SJ gratefully acknowledge funding from
Science Foundation Ireland grant 11/RFP.1/PHY/3165, Stokes
Lectureship to JJMcM and also from the Irish Research Council.
NG and EZ acknowledge support from MIUR Futuro in Ricerca
ANISOFT project (RBFR125H0M). NG and EZ thank L. Rovigatti
for useful discussions. Molecular graphics and analyses (Fig. 1)
were performed with the UCSF Chimera package. Chimera is
developed by the Resource for Biocomputing, Visualisation,
and Informatics at the University of California, San Francisco
(supported by NIGMS P41-GM103311).
References
1 E. Bianchi, R. Blaak and C. N. Likos, Phys. Chem. Chem.
Phys., 2011, 13, 6397–6410.
2 E. Bianchi, J. Largo, P. Tartaglia, E. Zaccarelli and F. Sciortino,
Phys. Rev. Lett., 2006, 97(16), 168301.
3 Q. Chen, S. C. Bae and S. Granick, Nature, 2011, 469,
381–384.
PCCP Paper
Pu
bl
is
he
d 
on
 2
1 
O
ct
ob
er
 2
01
5.
 D
ow
nl
oa
de
d 
by
 M
ay
no
ot
h 
U
ni
ve
rs
ity
 o
n 
30
/1
1/
20
15
 1
6:
09
:2
9.
 
View Article Online
31186 | Phys. Chem. Chem. Phys., 2015, 17, 31177--31187 This journal is© the Owner Societies 2015
4 S. C. Glotzer and M. J. Solomon, Nat. Mater., 2007, 6,
557–562.
5 G. Pellicane, G. Smith and L. Sarkisov, Phys. Rev. Lett., 2008,
101(24), 248102.
6 D. Fusco and P. Charbonneau, Colloids Surf., B, 2015, DOI:
10.1016/j.colsurfb.2015.07.023.
7 H. Rezvantalaba and S. Shojaei-Zadeh, Phys. Chem. Chem.
Phys., 2014, 16, 8283.
8 R. P. Sear, J. Chem. Phys., 1999, 111(10), 4800–4806.
9 A. Lomakin, N. Asherie and G. B. Benedek, Proc. Natl. Acad.
Sci. U. S. A., 1999, 96(17), 9465–9468.
10 C. D. Spicer and B. G. Davis, Nat. Commun., 2014, 5, 4740.
11 O. Boutureira and G. J. L. Bernardes, Chem. Rev., 2015, 115,
2174–2195.
12 H. Sahoo, RSC Adv., 2012, 2, 7017–7029.
13 F. M. Veronese, Biomaterials, 2001, 22, 405–417.
14 G. Walsh and R. Jefferis, Nat. Biotechnol., 2006, 24(10),
1241–1252.
15 S. I. van Kasteren, H. B. Kramer, H. H. Jensen, S. J.
Campbell, J. Kirkpatrick, N. J. Oldham, D. C. Anthony and
B. G. Davis, Nature, 2007, 446, 1105–1109.
16 F. H. Kasten, Fluorescent and luminescent probes for biological
activity, W.T. Mason, London, 2nd edn, 1999, pp. 17–39.
17 B. Huang, M. Bates and X. Zhuang, Annu. Rev. Biochem.,
2009, 78, 993–1016.
18 F. Hillger, D. Nettels, S. Dorsch and B. Schuler, J. Fluoresc.,
2007, 17(6), 759–765.
19 M. Pusey, J. Barcena, M. Morris, A. Singhal, Q. Yuan and
J. Ng, Acta Crystallogr., 2015, F71, 806–814.
20 J. Zhang, R. E. Campbell, A. Y. Ting and R. Y. Tsien,
Nat. Rev. Mol. Cell Biol., 2002, 3(12), 906–918.
21 A. Hawe, M. Sutter and W. Jiskoot, Pharm. Res., 2008, 25(7),
1487–1499.
22 Q. Zheng, M. F. Juette, S. Jockusch, M. R. Wasserman,
Z. Zhou, R. B. Altman and S. C. Blancharda, Chem. Soc.
Rev., 2014, 43(4), 1044–1056.
23 R. Y. Tsien, Annu. Rev. Biochem., 1998, 67, 509–544.
24 U. Resch-Genger, M. Grabolle, S. Cavaliere-Jaricot, R. Nitschke
and T. Nann, Nat. Methods, 2008, 5(9), 763–775.
25 N. Asherie, Methods, 2004, 34(3), 266–272.
26 S. James, M. K. Quinn and J. J. McManus, Phys. Chem. Chem.
Phys., 2015, 17(7), 5413–5420.
27 W. Li, B. A. Persson, M. Morin, M. A. Behrens, M. Lund and
M. Zackrisson Oskolkova, J. Phys. Chem. B, 2015, 119(2),
503–508.
28 F. Roosen-Runge, F. Zhang, F. Schreiber and R. Roth, Sci.
Rep., 2014, 4, 7016.
29 A. Gajraj and R. Y. Ofoli, Langmuir, 2000, 16(21), 8085–8094.
30 D. P. Richards, C. Stathakis, R. Polakowski, H. Ahmadzadeh
and N. J. Dovichi, J. Chromatogr. A, 1999, 853(1–2),
21–25.
31 L. S. De Clerck, C. H. Bridts, A. M. Mertens, M. M. Moens
and W. J. Stevens, J. Immunol. Methods, 1994, 172(1),
115–124.
32 J. Gunzenha¨user, R. Wyss and S. Manley, PLoS One, 2014,
9(12), e115095.
33 N. Asherie, A. Lomakin and G. B. Benedek, Phys. Rev. Lett.,
1996, 77(23), 4832–4835.
34 J. Mo¨ller, S. Grobelny, J. Schulze, S. Bieder, A. Steffen,
M. Erlkamp, M. Paulus, M. Tolan and R. Winter, Phys.
Rev. Lett., 2014, 112(2), 028101.
35 S. James and J. J. McManus, J. Phys. Chem. B, 2012, 116(34),
10182–10188.
36 F. Bonnete´, S. Finet and A. Tardieu, J. Cryst. Growth, 1999,
96(2–4), 403–414.
37 J. J. McManus, A. Lomakin, O. Ogun, A. Pande, M. Basan,
J. Pande and G. B. Benedek, Proc. Natl. Acad. Sci. U. S. A.,
2007, 104(43), 16856–16861.
38 M. L. Broide, T. M. Tominc and M. D. Saxowsky, Phys. Rev. E:
Stat. Phys., Plasmas, Fluids, Relat. Interdiscip. Top., 1996,
53(6), 6325–6335.
39 Y. Wang, A. Lomakin, J. J. McManus, O. Ogun and
G. B. Benedek, Proc. Natl. Acad. Sci. U. S. A., 2010, 107(30),
13282–13287.
40 P. R. Banerjee, A. Pande, J. Patrosz, G. M. Thurston and
J. Pande, Proc. Natl. Acad. Sci. U. S. A., 2011, 108(2), 574–579.
41 U. P. Andley, Prog. Retinal Eye Res., 2007, 26(1), 78–98.
42 J. F. Hejtmancik, Semin. Cell Dev. Biol., 2008, 19(2), 134–149.
43 E. He´on, M. Priston, D. F. Schorderet, G. D. Billingsley,
P. O. Girard, N. Lubsen and F. L. Munier, Am. J. Hum. Genet.,
1999, 65(5), 1261–1267.
44 P. Das, J. A. King and R. Zhou, Proc. Natl. Acad. Sci. U. S. A.,
2011, 108(26), 10514–10519.
45 A. Pande, J. Pande, N. Asherie, A. Lomakin, O. Ogun,
J. A. King, N. H. Lubsen, D. Walton and G. B. Benedek, Proc.
Natl. Acad. Sci. U. S. A., 2000, 97(5), 1993–1998.
46 M. L. Broide, C. R. Berland, J. Pande, O. O. Ogun and
G. B. Benedek, Proc. Natl. Acad. Sci. U. S. A., 1991, 88(13),
5660–5664.
47 H. Liu, S. K. Kumar and F. Sciortino, J. Chem. Phys., 2007,
127, 084902.
48 N. Kern and D. Frenkel, J. Chem. Phys., 2003, 118, 9882.
49 P. Virnau and M. Mueller, J. Chem. Phys., 2004, 120, 10925.
50 A. M. Ferrenberg and R. H. Swendsen, Phys. Rev. Lett., 1988,
61, 2635.
51 N. B. Wilding, J. Phys.: Condens. Matter, 1997, 9, 585–612.
52 F. Romano, P. Tartaglia and F. Sciortino, J. Phys.: Condens.
Matter, 2007, 19, 322101.
53 D. Nicolaides and A. D. Bruce, J. Phys. A: Math. Gen., 1988,
21, 233–234.
54 M. M. Tsypin and H. W. J. Blłote, Phys. Rev. E: Stat. Phys.,
Plasmas, Fluids, Relat. Interdiscip. Top., 2000, 62, 73–76.
55 L. Rovigatti, D. de las Heras, J. M. Tavares, M. M. Telo da Gama
and F. Sciortino, J. Chem. Phys., 2013, 138(16), 164904.
56 C. Liu, N. Asherie, A. Lomakin, J. Pande, O. Ogun and
G. B. Benedek, Proc. Natl. Acad. Sci. U. S. A., 1996, 93(1),
377–382.
57 A. Lomakin, N. Asherie and G. B. Benedek, J. Chem. Phys.,
1996, 104(4), 1646–1656.
58 Y. Wang, A. Lomakin, J. J. McManus, O. Ogun and
G. B. Benedek, Proc. Natl. Acad. Sci. U. S. A., 2010, 107(30),
13282–13287.
Paper PCCP
Pu
bl
is
he
d 
on
 2
1 
O
ct
ob
er
 2
01
5.
 D
ow
nl
oa
de
d 
by
 M
ay
no
ot
h 
U
ni
ve
rs
ity
 o
n 
30
/1
1/
20
15
 1
6:
09
:2
9.
 
View Article Online
This journal is© the Owner Societies 2015 Phys. Chem. Chem. Phys., 2015, 17, 31177--31187 | 31187
59 Q. Chen, P. G. Vekilov, R. L. Nagel and R. E. Hirsch, Biophys.
J., 2004, 86(3), 1702–1712.
60 J. Pande, A. Lomakin, B. Fine, O. Ogun, I. Sokolinski and G. B.
Benedek, Proc. Natl. Acad. Sci. U. S. A., 1995, 92(4), 1067–1071.
61 N. Asherie, J. Pande, A. Lomakin, O. Ogun, S. R. Hanson,
J. B. Smith and G. B. Benedek, Biophys. Chem., 1998, 75(3),
213–227.
62 J. A. Thomson, P. Schurtenberger, G. M. Thurston and
G. B. Benedek, Proc. Natl. Acad. Sci. U. S. A., 1987, 84(20),
7079–7083.
63 S. M. Kelly, T. J. Jess and N. C. Price, Biochim. Biophys. Acta,
2005, 1751(2), 119–139.
64 D. Fusco, J. J. Headd, A. De Simone, J. Wang and
P. Charbonneau, Soft Matter, 2014, 10(2), 290–302.
PCCP Paper
Pu
bl
is
he
d 
on
 2
1 
O
ct
ob
er
 2
01
5.
 D
ow
nl
oa
de
d 
by
 M
ay
no
ot
h 
U
ni
ve
rs
ity
 o
n 
30
/1
1/
20
15
 1
6:
09
:2
9.
 
View Article Online
